Hikma Pharmaceuticals (HKMPY) Stock Price, News & Analysis

Company Overview

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics. Its branded generics portfolio offers treatments in therapeutic areas such as cardiovascular, gastroenterology and pain management, primarily targeting emerging markets in the Middle East and North Africa. The speciality injectables segment includes oncology, anaesthesia and critical-care products, while the non-branded generics arm supplies a broad range of oral and injectable medicines to established markets in Europe and North America.

Hikma maintains a network of manufacturing facilities and R&D centres in Jordan, Portugal, the United Kingdom, Italy and the United States, enabling the company to serve customers in more than 50 countries. With an experienced executive leadership team and a board chaired by representatives of its founding Darwazah family, Hikma continues to pursue growth through strategic partnerships, targeted acquisitions and ongoing investment in product development and regulatory affairs.

Key Stats

• Today's Range: $47.48 to $48.06
• 50-Day Range: $43.05 to $50.56
• 52-Week Range: $43.00 to $59.26
• Volume: 8,056 shs
• Average Volume: 1,961 shs
• Market Capitalization: N/A
• P/E Ratio: 15.34
• Dividend Yield: 0.67%
• Price Target: N/A
• Consensus Rating: N/A

HKMPY Stock Analysis - Frequently Asked Questions

How have HKMPY shares performed this year?

Hikma Pharmaceuticals' stock was trading at $50.0075 on January 1st, 2025. Since then, HKMPY stock has decreased by 5.1% and is now trading at $47.4750.

How do I buy shares of Hikma Pharmaceuticals?

Shares of HKMPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Ex-Dividend for 9/29 Dividend: 8/18/2025
• Record date for 9/29 Dividend: 8/19/2025
• Dividend Payable: 9/29/2025
• Today: 10/19/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HKMPY
• CIK: N/A
• Web: www.hikma.com
• Phone: 442073992760
• Fax: N/A
• Employees: 9,100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 15.34
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A